Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Synchronization chemoradiotherapy for malignant gliomas].

H Yamamoto, F Sato, O Nakamura

    No Shinkei Geka. Neurological Surgery
    |June 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Troubles inherent to long-term home parenteral nutrition (HPN) and the use of technologies to improve communication between medical institutions and patients].

    Gan to kagaku ryoho. Cancer & chemotherapy·2002
    Same author

    [A case of terminal cancer patient whom the home staying terminal cares were provided with ease supported by the regional core hospital].

    Gan to kagaku ryoho. Cancer & chemotherapy·2001
    Same author

    [Home infusion therapy system from a resident's point of view].

    Gan to kagaku ryoho. Cancer & chemotherapy·2001
    Same author

    Immunohistochemical study of the distribution of Ca(2+)/calmodulin-dependent protein kinase phosphatase in the rat central nervous system.

    Brain research. Molecular brain research·2000
    Same author

    Paper is a compatible bed for rat hepatocytes.

    Artificial organs·2000
    Same author

    Molecular characterization of the S-adenosyl-L-methionine:3'-hydroxy-N-methylcoclaurine 4'-O-methyltransferase involved in isoquinoline alkaloid biosynthesis in Coptis japonica.

    The Journal of biological chemistry·2000

    Cellular synchronization chemoradiotherapy using VM26 or vincristine with ACNU improved survival rates for glioblastoma and malignant astrocytoma patients compared to standard radiation. This approach offers a promising therapeutic option with statistically confirmed higher responses and fewer side effects.

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Pharmacology

    Context:

    • Glioblastoma and malignant astrocytoma (Grade III) are aggressive brain tumors with limited treatment options.
    • Chemoradiotherapy is a standard treatment, but optimizing drug timing with radiation (cellular synchronization) may improve efficacy.
    • Previous studies have explored various chemotherapeutic agents in combination with radiation for brain tumors.

    Purpose:

    • To evaluate the efficacy of cellular synchronization chemoradiotherapy using VM26 (epipodophyllotoxin) or vincristine (VCR) combined with ACNU (nitrosourea) and radiation in patients with glioblastoma and malignant astrocytoma.
    • To compare the outcomes of two synchronization regimens: VM26 + ACNU + Radiation and VCR + ACNU + Radiation.
    • To compare the survival rates of the experimental groups with historical data from simple radiation therapy.

    Related Experiment Videos

    Summary:

    • A non-randomized clinical phase II trial involving 122 patients investigated two cellular synchronization chemoradiotherapy regimens.
    • The VM26 + ACNU + Radiation regimen showed an initial response rate of 30% (CR+PR) and 5-year survival of 25%.
    • The VCR + ACNU + Radiation regimen showed an initial response rate of 28% (CR+PR) and 5-year survival of 22%.
    • Both regimens demonstrated statistically significant improvements in initial response and long-term survival compared to historical simple radiation data (p < 0.01).

    Impact:

    • Cellular synchronization chemoradiotherapy, particularly with VM26 + ACNU, appears to be a more effective treatment strategy for malignant glioma.
    • The study suggests this approach offers statistically confirmed higher responses and potentially better long-term survival.
    • The findings support cellular synchronization chemoradiotherapy as a hopeful therapeutic method for malignant glioma, with potentially reduced side effects.